Brief: Transgene FY Net Loss Widens To EUR 32.8 Mln
March 16 (Reuters) - Transgene SA TRNG.PA :
* FINANCIAL VISIBILITY UNTIL EARLY 2024
* NET LOSS OF EUR 32.8 MILLION IN 2022, COMPARED TO A NET
LOSS OF
EUR 19.5 MILLION IN 2021
* OPERATING INCOME OF EUR 10.3 MILLION IN 2022, COMPARED TO
EUR
17.4 MILLION IN 2021
* CASH AVAILABLE AT YEAR-END 2022: EUR 26.8 MILLION,
COMPARED TO
EUR 49.6 MILLION AT END OF 2021
Source text for Eikon: ID:nBw8fCdJVa
Further company coverage: TRNG.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))
Recent news on Transgene SA
See all newsFrance's Transgene H1 operating income falls on lower tax credit
Transgene jumps 20% on positive cancer vaccine data in early trial
Brief: Transgene & NEC Bio Sign License Agreement To Prepare Next Steps Of Development Of TG4050 In Head & Neck Cancer
Brief: Transgene SA Says Myvac Platform To Initiate Phase 1 Trial In Second Indication In 2026
France's Transgene 2025 net loss widens on higher financial costs